Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.82 |
| ▸ | APEX1 | P27695 | 7/20 | 0.82 |
| ▸ | CTDSP1 | Q9GZU7 | 4/20 | 0.82 |
| ▸ | APOBEC3A | P31941 | 3/20 | 0.82 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.82 |
| ▸ | MAPT | P10636 | 8/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.71 |
| ▸ | POLB | P06746 | 8/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.71 |
| ▸ | RECQL | P46063 | 3/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.71 |
| ▸ | IDH1 | O75874 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.60 |
| ▸ | MEN1 | O00255 | 6/20 | 0.60 |
| ▸ | PKM | P14618 | 4/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5145258 | 1.00 | KDM4E (0.82) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL14751 | 0.82 | IDH1 (1.00) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL6393742 | 0.79 | TDP1 (0.79) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL6393226 | 0.79 | TDP1 (0.79) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL6391164 | 0.77 | TDP1 (0.83) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL6391161 | 0.77 | TDP1 (0.83) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL5146587 | 0.72 | TDP1 (0.74) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL6393879 | 0.72 | TDP1 (0.74) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL5145280 | 0.71 | KDM4E (0.43) | KDM4ETDP1APEX1CTDSP1APOBEC3A | |
| SCHEMBL21538196 | 0.70 | IDH1 (0.67) | KDM4ETDP1APEX1CTDSP1APOBEC3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1718308-A4 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PAINCEPTOR PHARMA CORP (CA) | 2007-07-18 | — | — | EP | disclosed |
| EP-1718308-A2 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PainCeptor Pharma Corp. (CA) | 2006-11-08 | — | — | EP | disclosed |
| US-20050282840-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2005-12-22 | — | — | US | disclosed |
| WO-2005076695-A2 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PAINCEPTOR PHARMA CORPORATION (CA) | 2005-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282840-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | KDM4E 4569/4885TDP1 1996/4885APEX1 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.